e-learning
resources
Milan 2017
Wednesday, 13.09.2017
What is new in COPD management and prognosis: findings from large studies?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results
A. Protasov (Samara, Russian Federation)
Source:
International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Session:
What is new in COPD management and prognosis: findings from large studies?
Session type:
Poster Discussion
Number:
4954
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Protasov (Samara, Russian Federation). Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results. 4954
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): A two-year study
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006
Pneumococcal vaccination coverage in Spanish patients with chronic obstructive pulmonary disease (COPD). Result of the EPIDEPOC study
Source: Eur Respir J 2004; 24: Suppl. 48, 144s
Year: 2004
Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Effects of pulmonary rehabilitation on different outcomes and at different times in subjects suffering from stable COPD
Source: Annual Congress 2006 - Outcomes in pulmonary rehabilitation
Year: 2006
Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 442s
Year: 2006
Exacerbations of chronic obstructive pulmonary disease (COPD): Correlation of hospitalization days with epidemiological and clinical parameters
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Exacerbations and associated health-care cost in patients with chronic obstructive pulmonary disease (COPD) in general practice. Results from the COOPT trial
Source: Eur Respir J 2002; 20: Suppl. 38, 398s
Year: 2002
Vaccination efficacy in workers with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 107s
Year: 2006
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: management
Year: 2010
Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 372s
Year: 2007
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease?
Source: Annual Congress 2003 - COPD: risk factors and course of disease
Year: 2003
The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept